• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
 
Generic Name:  sildenafil
Date Designated:  07/28/2011
Orphan Designation:  Treatment of pediatric (defined as children less than 17 years of age) pulmonary arterial hypertension
Orphan Designation Status:  Designated
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
Pfizer, Inc.
Worldwide Regulatory strategy
New York, New York 10017
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.
-
-